Diagnostic accuracy of serum brain derived neurotrophic factor concentration in antidepressant naïve patients with first major depression episode

Journal of Psychiatric Research

Volumn 47, Issue 2, 2013, Pages 162-167

  Karlović, Dalibor ^a   Serretti, Alessandro ^b   Jevtović, Saša ^c   Vrkić, Nada ^d   Šerić, Vesna ^d   Peleš, Alma Mihaljević ^c  

^a KBC Zagreb   (Croatia)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Brain derived neurotrophic factor; Diagnostic biomarker; Major depressive disorder; Operating characteristic analysis

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; AREA UNDER THE CURVE; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DSM-IV-TR; EDUCATIONAL STATUS; EMPLOYMENT STATUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HAMILTON SCALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MARRIAGE; MENTAL PATIENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PSYCHOPHARMACOTHERAPY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

EID: 84871525854     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.09.017     Document Type: Article

References (38)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, Text revision, American Psychiatric Association, Washington DC. 4th ed.
2. Angelucci F., Brenè S., Mathé A.A. BDNF in schizophrenia, depression and corresponding animal models. Molecular Psychiatry 2005, 10:345-352.
3. Aydemir O., Deveci A., Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Progress in Neuropsychopharmacology and Biological Psychiatry 2005, 29:261-265.
4. Aydemir C., Yalcin E.S., Aksaray S., Kisa C., Yildirim S.G., Uzbay T., et al. Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Progress in Neuropsychopharmacology and Biological Psychiatry 2006, 30:1256-1260.
5. Aydemir O., Deveci A., Taskin O.E., Taneli F., Esen-Danaci A. Serum brain-derived neurotrophic factor level in dysthymia: a comparative study with major depressive disorder. Progress in Neuropsychopharmacology and Biological Psychiatry 2007, 31:1023-1026.
6. Birkenhäger T.K., Geldermans S., Van den Broek W.W., van Beveren N., Fekkes D. Serum brain-derived neurotrophic factor level in relation to illness severity and episode duration in patients with major depression. Journal of Psychiatric Research 2012, 46:285-289.
7. Bocchio-Chiavetto L., Zanardini R., Bortolomasi M., Abate M., Segala M., Giacopuzzi M., et al. Electroconvulsive therapy (ECT) increases serum brain derived neurotrophic factor (BDNF) in drug resistant depressed patients. European Neuropsychopharmacology 2006, 16:620-624.
8. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis P.P., Glasziou P.P., Irwig L.M., et al. Standards for Reporting of Diagnostic Accuracy. The STARD statement for reporting of diagnostic accuracy: explanation and elaboration. Clinical Chemistry 2003, 49:7-18.
9. Brunoni A.R., Lopes M., Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. International Journal of Neuropsychopharmacology 2008, 11:1169-1180.
10. Bus B.A., Molendijk M.L., Penninx B.J., Buitelaar J.K., Kenis G., Prickaerts J., et al. Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology 2011, 36:228-239.
11. Castren E., Rantamaki T. The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Developmental Neurobiology 2010, 70:89-297.
12. Dell Osso L., Del Debbio A., Veltri A., Bianchi C., Roncaglia I., Carlini M., et al. Associations between brain-derived neurotrophic factor plasma levels and severity of the illness, recurrence and symptoms in depressed patients. Neuropsychobiology 2010, 62:207-212.
13. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biological Psychiatry 2006, 59:1116-1127.
14. Fernandes B.S., Gama C.S., Ceresér K.M., Yatham L.N., Fries G.R., Colpo G., et al. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. Journal of Psychiatry Research 2011, 45:995-1004.
15. Gervasoni N., Aubry J.M., Bondolfi G., Osiek C., Schwald M., Bertschy G., et al. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 2005, 51:234-238.
16. Gonul A.S., Akdeniz F., Taneli F., Donat O., Eker C., Vahip S. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. European Archives of Psychiatry and Clinical Neuroscience 2005, 255:381-386.
17. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960, 23:56-62.
18. Huang T.L., Lee C.T., Liu Y.L. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants. Journal of Psychiatric Research 2008, 42:521-525.
19. Jevtović S., Karlović D., Mihaljević-PeleŠ A., Vrkić N., Šerić V., JakŠić N. Serum Brain-derived neurotrophic factor (BDNF): the severity and symptomatic dimensions of depression. Psychiatrya Danubina 2011, 23:363-369.
20. Karege F., Vaudan G., Schwald M., Perroud N., La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Research. Molecular Brain Research 2005, 136:29-37.
21. Karlović D., Serretti A., Vrkić N., Martinac M., Marčinko D. Serum concentrations of CRP, IL-6, TNF-α, and cortisol in major depressive disorder with melancholic or atypical features. Psychiatry Research 2012, 198:74-80.
22. Kim Y.K., Lee H.P., Won S.D., Park E.Y., Lee H.Y., Lee B.H., et al. Low plasma BDNF is associated with suicidal behavior in major depression. Progress in Neuropsychopharmacology and Biological Psychiatry 2007, 31:78-85.
23. Lakhan S.E., Vieira K., Hamlat E. Biomarkers in psychiatry: drawbacks and potential for misuse. International Archives of Medicine 2010, 3:1.
24. Lee B.H., Kim H., Park S.H., Kim Y.K. Decreased plasma BDNF level in depressive patients. Journal of Affective Disorders 2007, 101:239-244.
25. Marano C.M., Phatak P., Vemulapalli U.R., Sasan A., Nalbandyan M.R., Ramanujam S., et al. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression. Journal of Clinical Psychiatry 2007, 68:512-517.
26. Martinowich K., Manji H., Lu B. New insights into BDNF function in depression and anxiety. Nature Neuroscience 2007, 10:1089-1093.
27. Matrisciano F., Bonaccorso S., Ricciardi A., Scaccianoce S., Panaccione I., Wang L., et al. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. Journal of Psychiatric Research 2009, 43:247-254.
28. Okamoto T., Yoshimura R., Ikenouchi-Sugita A., Hori H., Umene-Nakano W., Inoue Y., et al. Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neutrophic factor (BDNF) in refractory depressed patients: a pilot study. Progress in Neuropsychopharmacology and Biological Psychiatry 2008, 32:1185-1190.
29. Perlis R.H., Duman R.S. Betting on biomarkers. American Journal of Psychiatry 2007, 168:234-323.
30. Piccinni A., Marazziti D., Catena M., Domenici L., Del Debbio A., Bianchi C., et al. Plasma and serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. Journal of Affective Disorders 2008, 105:279-283.
31. Posternak M.A., Solomon D.A., Leon A.C., Mueller T.I., Shea M.T., Endicott J., et al. The naturalistic course of unipolar major depression in the absence of somatic therapy. Journal of Nervous and Mental Disease 2006, 194:324-329.
32. Schmidt H.D., Duman R.S. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behavioural Pharmacology 2007, 18:391-418.
33. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biological Psychiatry 2008, 64:527-532.
34. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 1998, 59(Suppl. 20):34-57.
35. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biological Psychiatry 2003, 54:70-75.
36. Silić A., Karlović D., Serretti A. Increased inflammation and lower platelet 5-HT in depression with metabolic syndrome. Journal of Affective Disorders 2012, 141:72-78.
37. Yoshimura R., Mitoma M., Sugita A., Hori H., Okamoto T., Umene W., et al. Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Progress in Neuropsychopharmacology and Biological Psychiatry 2007, 31:1034-1037.
38. Zanardini R., Gazzoli A., Ventriglia M., Perez J., Bignotti S., Rossini P.M., et al. Effect of repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor in drug resistant depressed patients. Journal of Affective Disorders 2006, 91:83-86.